Inventor · disambiguated record
Christian Belmant
Also filed as: BELMANT CHRISTIAN
14 granted patents·8 pending applications·200 citations·filing 1999–2017
93Inventor score
Top patents by PatentIndex Score
22 records- 0197US9717803B2Enzymatic conjugation of polypeptidesINNATE PHARMA·Filed 2012·Granted Aug 1, 2017·29 cites·40 claims
- 0296US10675359B2Enzymatic conjugation of antibodiesINNATE PHARMA·Filed 2017·Granted Jun 9, 2020·11 cites·24 claims
- 0396US9764038B2Enzymatic conjugation of antibodiesINNATE PHARMA·Filed 2012·Granted Sep 19, 2017·38 cites·13 claims
- 0494US10434180B2Enzymatic conjugation of polypeptidesINNATE PHARMA·Filed 2016·Granted Oct 8, 2019·20 cites·13 claims
- 0594US9427478B2Enzymatic conjugation of polypeptidesINNATE PHARMA·Filed 2014·Granted Aug 30, 2016·30 cites·21 claims
- 0684US7109183B2Phosphohalohydrins, process for the production thereof and use thereofINST NAT SANTE RECH MED·Filed 2003·Granted Sep 19, 2006·13 cites·10 claims
- 0783US7625879B2Phosphohalohydrins, process for the production thereof and use thereofINST NAT SANTE RECH MED·Filed 2006·Granted Dec 1, 2009·2 cites·33 claims
- 0882US7432253B2Phosphoepoxides, method for making same and usesINST NAT SANTE RECH MED·Filed 2006·Granted Oct 7, 2008·4 cites·48 claims
- 0980US6624151B1Compounds selectively inhibiting gamma 9 delta 2 T lymphocytesINST NAT SANTE RECH MED·Filed 2000·Granted Sep 23, 2003·14 cites·4 claims
- 1078US10132799B2Screening of conjugated antibodiesINNATE PHARMA·Filed 2013·Granted Nov 20, 2018·3 cites·22 claims
- 1173US6660723B1Phosphalohydrins and methods for medicinal administrationINST NAT SANTE RECH MED·Filed 1999·Granted Dec 9, 2003·24 cites·14 claims
- 1272US7683045B2Class of γδ T cells activators and use thereofINNATE PHARMA SA·Filed 2006·Granted Mar 23, 2010·1 cites·42 claims
- 1366US2010068179A1Phosphohalohydrins, Process For The Production Thereof And Use ThereofINST NAT SANTE RECH MED·Filed 2009·Application pending·0 cites
- 1457US7101711B1Phosphoepoxides, method for making same and usesINST NAT SANTE RECH MED·Filed 1999·Granted Sep 5, 2006·11 cites·17 claims
- 1557US2018071402A1Enzymatic conjugation of polypeptidesINNATE PHARMA·Filed 2017·Application pending·0 cites
- 1650US2011076296A1TLR3 Agonist CompositionsINNATE PHARMA SA·Filed 2009·Application pending·0 cites
- 1744US2004009123A1Compounds selectively inhibiting gamma 9 delta 2 T lymphocytesINST NAT SANTE RECH MED·Filed 2003·Application pending·0 cites
- 1844US2004006131A1Compounds selectively inhibiting gamma 9 delta 2 T lymphocytesINST NAT SANTE RECH MED·Filed 2003·Application pending·0 cites
- 1942US2010254940A1Compositions and Methods for Regulating an Immune Response in a SubjectINNATE PHARMA SA·Filed 2010·Application pending·0 cites
- 2042US2010222306A1Class of Gamma Delta T Cells Activators and Use ThereofINNATE PHARMA SA·Filed 2010·Application pending·0 cites
- 2137US7767842B2Class of γδ T cells activators and use thereofINNATE PHARMA SA·Filed 2004·Granted Aug 3, 2010·0 cites·14 claims
- 2227US2010291118A1Class of Gamma Delta T Cells Activators and Use ThereofINNATE PHARMA·Filed 2010·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →